3864 J ournal of Medicinal Chemistry, 2003, Vol. 46, No. 18
Anzini et al.
(22) Meurisse, R. L.; Hevlen, L.; Leysen, J . E.; Meunier, J . C.; De
Ranter, C. Radioligand Binding Profile of Enantiomers of
Tifluadom Analogues for Opioid, CCK, and Central Benzodiaz-
epine Receptors: Versatility of Benzodiazepine Skeleton. Regul.
Pept. 1984, 1, 5347-5248.
(23) Azzolina, O.; Collina, S.; Linati, L.; Anzini, M.; Cappelli, A.;
Scheideler M. A.; Sbacchi, M. Enantiomers of 2[(Acylamino)-
ethyl]-1,4-benzodiazepiones, Potent Ligands of k-Opioid Recep-
tor: Chiral Chromatographic Resolution, Configurational As-
signment, and Biological Activity. Chirality 2001, 13, 606-612.
(24) Palczewski, K.; Kumasaka, T.; Hori, T.; Behnke, C. A.; Mo-
toshima, H.; Fox, B. A.; Le Trong, I.; Teller, D. C.; Okada, T.;
Stenkamp, R. E.; Yamamoto, M.; Miyano, M. Crystal Structure
of Rhodopsin: A G-Protein-Coupled Receptor. Science 2000, 289,
739-745.
(25) Ghelardini, C.; Galeotti, N.; Bartolini, A.; Anzini, M.; Cappelli,
A.; Vomero, S. Antiamnesic Effect of the Two Novel k-Opioid
Agonists, VA 100 and VA 101, in the Mouse Passive Avoidance
Test. Drug Dev. Res. 2001, 54, 12-18.
(26) Anzini, M.; Cappelli, A.; Vomero, S. Synthesis and Receptor
Binding Studies of 2-Functionalized 1,4-Benzodiazepine Deriva-
tives as Potential Metaclazepam-like Antianxiety Agents. Far-
maco 1993, 48, 897-905.
(27) Anzini, M.; Garofalo, A.; Vomero, S. Syntheses of Functionalized
Derivatives of Quinazolines and 1,4-Benzodiazepines. Hetero-
cycles 1989, 29, 1477-1487.
(28) Fryer, R. I.; Pinto, J . C.; Upasani, R. B. Studies Related to
Alkylations of Enolate Anions of 1,4-Benzodiazepinones. J .
Heterocyclic Chem. 1993, 30, 945-951.
(29) Walser, A.; Flynn, T.; Fryer, R. I. Quinazolines and 1,4-
Benzodiazepines. Lxxxv (I). Sintheses of 3-Substituted Imidazo-
[1,5-a][1,4]benzodiazepines. J . Heterocyclic Chem. 1978, 15, 577-
583.
(30) Petcher, T. J .; Widmer, A.; Maetzel, U.; Zeugner, H. Structures
of Tifluadom [5-(2-fluorophenyl)-1-methyl-2-(3-thenoyl-amino-
ternation Performance in the Mouse. Eur. J . Pharmacol. 1995,
81, 173-178.
(41) Hiramatsu, M.; Murasawa, H.; Nabeshima, T.; Kameyama, T.
Effects of U-50,488H on Scopolamine-, Mecamylamine- and
Dizocilpine-Induced Learning and Memory Impairment in Rats.
J . Pharmacol. Exp. Ther. 1998, 284, 858-867.
(42) Henderson, R.; Baldwin, J .; Ceska, T. H.; Zemlin, F.; Beckmamn,
E.; Downing, K. Model of the Structure of Bacteriorhodopsin
Based on High-Resolution Electron Cryomicroscopy. J . Mol. Biol.
1990, 213, 899-919.
(43) Baldwin, J . M. The Probable Arrangement of the Helices in G
Protein-Coupled Receptors. The EMBO J . 1993, 12, 1693-1703.
(44) Ballesteros, J . A.; Weinstein, H. Analysis and Refinement of
Criteria for Predicting the Structure and Relative Orientations
of Transmembranal Helical Domains. Biophys. J . 1992, 62, 107-
109.
(45) Beukers, M. W.; Kristiansen, K.; Ijzerman, A. P.; Edvardsen,
Ø. TinyGRAP Database:
a Bioinformatics Tool to Mine G
Protein-Coupled Receptor Mutant Data. TiPS 1999, 20, 475-
477.
(46) Mansour, A.; Taylor, L. P.; Fine, J . L.; Thompson, R. C.;
Hoversten, M. T.; Mosberg, H. I.; Watson, S. J .; Akil, H. Key
Residues Defining the µ-Opioid Receptor Binding Pocket: a Site-
Directed Mutagenesis Study. J . Neurochem. 1997, 68, 344-353.
(47) Xu, W.; Li, J .; Chen, C.; Huang, P.; Weinstein, H.; J avitch, J .
A.; Shi, L.; De Riel, J . K.; Liu Chen, L. Y. Comparison of the
Amino acid Residues in the Sixth Transmembrane Domains
Accessible in the Binding-Site Crevices of mu, delta, and kappa
Opioid Receptors. Biochemistry 2001, 40, 8018-8029.
(48) Metzger, T. G.; Paterlini, M. G.; Ferguson, D. M.; Portoghese,
P. S. Investigation of the Selectivity of Oxymorphone- and
Naltrexone-Derived Ligands via Site-Directed Mutagenesis of
Opioid Receptors: Exploring the “Address” Recognition locus.
J . Med. Chem. 2001, 44, 857-62.
(49) Sali, A.; Blundell, T. L. Comparative Protein Modeling by
Satisfaction of Spatial Restraints. J . Mol. Biol. 1993, 234, 779-
815.
methyl)-2,3-dihydro-1H- 1,4-benzodiazepine]Hydrochloride, C22H21
-
FN3OS+‚Cl-,and of(+)-Tifluadom p-Toluenesulphonate,C22H21FN3-
OS+‚C7H7O3S-, and the Absolute Configuration of the Latter.
Acta Cryst. 1985, C41, 909-912.
(50) Thompson J . D.; Higgins D. G.; Gibson T. CLUSTAL W:
Improving the Sensitivity of Progressive Multiple Sequence
Alignment Through Sequence Weighting, Position-Specific Gap
Penalties and Weight Matrix Choice. J . Nucleic Acids Res. 1994,
22, 4673-4680.
(31) Kotzer, C. J .; Hay, D. W. P.; Dondio, M.; Giardina, G. A. M.;
Petrillo, P.; Underwood, D. The Antitussive Activity of Delta
Opioid Receptor Stimulation in Guinea Pigs. J . Pharmacol. Exp.
Ther. 2000, 292, 803-809.
(32) Leighton, G. E.; Rodriguez, R. E.; Hill, R. G.; Hughes, J . kappa-
Opioid Agonists Produce Antinociception after i.v. and icv but
not Intrathecal Administration in the Rat. Br. J . Pharmacol.
1988, 93, 553-560.
(33) Pelissier, T.; Paeile, C.; Soto-Moyano, R.; Saavedra, H.; Her-
nandez, A. Analgesia Produced by Intrathecal Administration
of the kappa Opioid Agonist, U-50, 488H, on Formalin-Evoked
Cutaneous Pain in the Rat. Eur J . Pharmacol. 1990, 190, 287-
293.
(34) Endoh, T.; Matsuura, H.; Tajima. A.; Izumimoto, N.; Tajima, C.;
Suzuki, T.; Saitoh, A.; Suzuki, T.; Marita, M.; Tseng, L.; Nagase,
H. Potent Antinociceptive Effects of TRK-820, a Novel kappa-
Opioid Receptor Agonist. Life Sci. 1999, 65, 1685-1694.
(35) Stevens, C. W.; Yaksh, T. L. Dynorphin A and Related Peptides
Administered Intrathecally in the Rat: A Search for Putative
kappa Opiate Receptor Activity. J . Pharmacol. Exp. Ther. 1986,
238, 833-838.
(36) Colombo, P. J .; Martinez, J . L.; Bennet, E. L.; Rosenzweig, M.
R. k-Opioid Receptor Activity Modulates Memory for Peck-
Avoidance Training in the 2-Day-Old Chick. Psycopharmacology
1992, 108, 235-241.
(37) Ukai, M.; Itoh, J .; Kobayashi, T.; Shinkai, N.; Kameyama, T.
Effects of the k-Opioid Dynorphin A-(1-13) on Learning and
Memory in Mice. Behav. Brain Res. 1997, 83, 169-172.
(38) Hiramatsu, M.; Inoue, K.; Kameyama, T. Dynorphin A-(1-13)
and (2-13) Improve â-Amyloid Peptide-Induced Amnesia in
Mice. Neuroreport 2000, 11, 431-435.
(39) Ukai, M.; Shan-Wu, Y.; Kobayashi, T.; Kameyama, T. Systemic
Administration of Dynorphin A-(1-13) Markedly Improves
Cycloheximide-Induced Amnesia in Mice. Eur. J . Pharmacol.
1996, 313, 11-15.
(40) Ukai, M.; Shinkai, N.; Kameyama, T. k-Opioid Receptor Agonists
Improve Pirenzepine-Induced Disturbance of Spontaneous Al-
(51) Brooks, B. R.; Bruccoleri, R. E.; Olafson, B. D.; States, D. J .;
Swaminathan, S.; Karplus, M. CHARMM:
a Program for
Macromolecular Energy Minimization and Dynamics Calcula-
tions. J . Comput. Chem. 1983, 4, 187-217.
(52) van Gunsteren, W. F.; Berendsen, J . C. Algorithms for Macro-
molecular Dynamics and Constraint Dynamics. Mol. Phys. 1977,
34, 1311-1327.
(53) Menziani, M. C.; De Benedetti, P. G.; Gago, F.; Richards, W. G.
The Binding of Benzensulphonamides to Carbonic Anhidrase
Enzyme. A Molecular Mechanics Study and Quantitative Struc-
ture-Activity Relationships. J . Med. Chem. 1989, 32, 951-956.
(54) Scheideler, M. A.; Zukin, R. S. Reconstitution of Solubilized
Delta-Opiate Receptor Binding Sites in Lipid Vesicles. J . Biol.
Chem. 1990, 265, 15176-15182.
(55) Baron, B. M.; Siegel, B. W.; Slone, A. L.; Harrison, B. L.;
Palfreyman, M. G.; Hurt, S. D. [3H]5,7-Dichlorokynurenic Acid,
a Novel Radioligand Labels NMDA Receptor-Associated Glycine
Binding Sites. Eur. J . Pharmacol. 1991, 206, 149-154.
(56) Cheng, Y. C.; Prusoff, W. H. Relationship Between the Inhibition
Constant (Ki) and the Concentration of Inhibitor Which Causes
50 Per Cent Inhibition (I50) of an Enzymatic Reaction. Biochem.
Pharmacol. 1973, 22, 3099-3108.
(57) O’Callaghan, J . P.; Holtzman, S. G. Quantification of the
Antinociceptive Activity of Narcotic Antagonists by a Modified
Hot-Plate Procedure. J . Pharmacol. Exp. Ther. 1975, 192, 497-
505.
(58) J arvik, M. E.; Kopp, R. An Improved One-Trial Passive Avoid-
ance Learning Situation. Psychol. Rep. 1967, 21, 221-224.
(59) Haley, T. J .; McCormick, W. G. Pharmacological Effects Pro-
duced by Intracerebral Injection of Drugs in the Conscious
Mouse. Br. J . Pharmacol. Chemother. 1957, 12, 12-15.
J M0307640